Explicit Modelling of Antibody Levels for Infectious Disease Simulations in the Context of SARS-CoV-2
S. A. Mueller, S. Paltra, J. Rehmann, K. Nagel, T. O. F. Conrad
This paper introduces a methodology to explicitly model antibody levels and waning effects in an agent-based model to improve infection risk calculations during infectious disease outbreaks.
bioRxiv · Mar 31, 2023Immunology